What is Certolizumab?

Category: Prescription Drugs

Most popular types: Cimzia

false

Certolizumab is an injectable product that can be used to treat a number of autoimmune conditions including: Crohn's disease, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 62 31
Crohn's disease 26 20
Ankylosing spondylitis 9 7
Psoriatic arthritis 8 8
Psoriasis 4 3
Behcet's disease 1 0

Show all 13 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 5
Moderate 14
Mild 21
None 28

Commonly reported side effects and conditions associated with Certolizumab

Side effect Patients Percentage
Headaches 4
Fatigue 3
Diarrhea 2
Rash on arm 2
Blurry vision 1
Breathing difficulty 1

Show all 31 reported side effects

Dosages

Based on patients currently taking Certolizumab

Dosage Patients Percentage
400 mg monthly 2
400 mg every other week 1
80000 mg one time 1

Why patients stopped taking Certolizumab

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 28
Doctor's advice 14
Side effects too severe 7
Change in health plan coverage 2
Course of treatment ended 1
Expense 1
Other 1
See all 42 patients who've stopped taking Certolizumab

Duration

Currently taking Certolizumab

Duration Patients Percentage
1 - 2 years 2
2 - 5 years 3
5 - 10 years 1

Stopped taking Certolizumab

Duration Patients Percentage
Less than 1 month 5
1 - 6 months 9
6 months - 1 year 13
1 - 2 years 10
2 - 5 years 5
Adherence
Adherence Evaluations Percentage
Always 62
Usually 3
Sometimes 1
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 3
Somewhat hard to take 9
A little hard to take 33
Not at all hard to take 23
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 11
$25-49 4
< $25 27
Not specified 25

What people switch to and from

Patients started taking Certolizumab after stopping:

Treatment Patients Percentage
Adalimumab (Humira) 18
Etanercept (Enbrel SureClick) 7
Infliximab (Remicade) 6
Golimumab (Simponi SmartJect) 3
Abatacept (Orencia) 2

Show all 16 treatments patients report switching from

Patients stopped taking Certolizumab and switched to:

Treatment Patients Percentage
Abatacept (Orencia) 6
Adalimumab (Humira) 2
Rituximab (Rituxan) 2
Tocilizumab (Actemra) 2
Tofacitinib (Xeljanz) 2

Show all 9 treatments patients report switching to

Last updated:
There are no evaluations for Certolizumab.